Skip to main content

Advocacy

Technologies like CGM and insulin pumps have the potential to revolutionize a person’s diabetes care and management. Unfortunately, too many people with diabetes,...
Every February, the Spare a Rose campaign raises funds to provide insulin and other diabetes supplies to people with type 1 in under-resourced countries. Spread the word...
A1C, crucial for diabetes management, varies by race, affecting accuracy. Supplementary measures like TIR offer a more tailored approach.
Diagnosed with type 2 diabetes at 23, Liz Kopco shares her journey from a health-conscious lifestyle to confronting diabetes stigmas and stereotypes, emphasizing the...
Understand the stigma linked to medication use for diabetes and obesity management. Let's change the perception and enhance our healthcare conversations.
In a recent study, results showed that improved access to CGM can lower A1C levels in Hispanic children. However, broader societal strategies are needed to address...
California Gov. Gavin Newsom announced a $50-million contract with Civica Rx to produce the state’s own insulin, adding to the recent new policies aiming to make this...
Getting your questions answered in your limited time with your healthcare provider can be frustrating. Here are some strategies you can use to ensure you're getting the...
Starting in 2023, Delaware residents will not have to pay more than $35 per month for diabetes supplies and equipment such as glucose meters, continuous glucose monitors...
diaTribe writer and editor Jim Hirsch reviews an outstanding new PBS documentary that explores and gives new voices to the diabetes epidemic in the US
At our virtual Musings Under the Moon #8 gathering, experts in health equity gathered to discuss what health equity really means, what its barriers are, and what actions...
When you’re diagnosed with diabetes, your healthcare providers can’t answer all your questions. Meeting others with diabetes can be a great way to learn from experience...
The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...
India is a developing country where diabetes is highly prevalent. Leading endocrinologists shared how they use the messaging service WhatsApp and Professional CGMs to...
At the ATTD 2022 conference, diabetes advocates delivered presentations on open-source AID, access to insulin and diabetes supplies, and diabetes stigma in the #dedocº...
Black, Indigenous, Hispanic, and Asian individuals, and people of all non-white racial and ethnic groups are more likely to have diabetes and diabetes-related health...
The US Preventive Services Task Force (USPSTF) has updated its recommendations, encouraging prediabetes and type 2 diabetes screening for people with excess weight or...
diaTribe spoke with Dr. Nick Cuttriss, founding director of the ECHO Diabetes Action Network (EDAN), to learn how Project ECHO Diabetes and EDAN use telementoring to...
Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance...
US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of...

Pages